Congenital syphilis screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 16: | Line 16: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
{{reflist|2}} | |||
[[Category:Disease]] | [[Category:Disease]] |
Revision as of 17:24, 20 December 2012
Congenital syphilis Microchapters |
Diagnosis |
Treatment |
Case Studies |
Congenital syphilis screening On the Web |
American Roentgen Ray Society Images of Congenital syphilis screening |
Risk calculators and risk factors for Congenital syphilis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2]
Overview
Routine screening of newborn serum or umbilical cord blood is not recommended. Serologic testing of the mother’s serum is preferred rather than testing of the infant’s serum.
Screening
- Newborn serum is not used for serologic tests instead mother's serum is prefered. [1]
- The serologic tests performed on infant serum can be nonreactive if the mother’s serologic test result is of low titer or the mother was infected late in pregnancy.
- Screening can be performed using either a nontreponemal or treponemal test. If either screening test is positive, testing must be performed immediately using the other complimentary test (i.e., nontreponemal test followed by treponemal test or vice-versa).
- No infant or mother should leave the hospital unless maternal serologic status has been documented at least once during pregnancy; in communities and populations in which the risk for congenital syphilis is high, documentation should also occur at delivery.